Meeting
2020 ASCO Virtual Scientific Program
Neutrophil-lymphocyte score: A novel prognostic scoring system that utilized the dynamic change of neutrophil, lymphocyte, and albumin and its comparison to other indices.
Authors
Songzhu Zhao
Center for Biostatistics, The Ohio State University, Columbus, OH
Songzhu Zhao , Mingjia Li , Daniel Spakowicz , Sandip H. Patel , Andrew Johns , Madison Grogan , Abdul Miah , Marium Husain , Kai He , Erin Marie Bertino , Peter G. Shields , Lai Wei , David Paul Carbone , Gregory Alan Otterson , Carolyn J Presley , Dwight Hall Owen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Immunotherapy
Track
Developmental Therapeutics—Immunotherapy
Sub Track
Circulating Biomarkers
Citation
J Clin Oncol 38: 2020 (suppl; abstr 3048)
DOI
10.1200/JCO.2020.38.15_suppl.3048
Abstract #
3048
Poster Bd #
112
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
The predictive value of hematological markers in renal cell carcinoma.
First Author: Omar Al Ta'ani
Poster
2023 ASCO Genitourinary Cancers Symposium
Predictive value of C reactive protein (CRP) in patients with metastatic renal cell carcinoma (mRCC) treated with pembrolizumab (pembro) and axitinib (axi).
First Author: Aitzaz Qaisar
Poster
2022 ASCO Annual Meeting
The prognostic value of peripheral blood inflammatory indices early variation in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with nivolumab (Δ-Meet-URO analysis).
First Author: Sara Elena Rebuzzi
Poster
2022 ASCO Genitourinary Cancers Symposium
Early changes in peripheral blood neutrophil-lymphocyte ratio (NLR) predicts outcomes with immune checkpoint inhibitors (ICIs) for metastatic urothelial carcinoma (mUC).
First Author: Jonathan Thomas